Plain-English translation of NCT06241560 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Researchers want to understand whether , a medicine already used to treat lung fibrosis, changes how much of a new experimental medicine called stays in your bloodstream. When you take multiple medicines at once, they can sometimes affect how each other works in your body. This study helps doctors understand that interaction so they can safely use both treatments together.
Many people with lung fibrosis need to take more than one medicine. Before doctors can safely recommend using this medication alongside , they need to know exactly how these two drugs interact in the body and whether one changes how much of the other gets absorbed into your blood.
You will take one dose of the new medication, then gradually increase doses of over three weeks, then take another dose of the new medication. Throughout the study (about one month), you'll visit the research site 15 times, including two overnight stays. During visits, doctors will take blood samples and check your health. The study team will also call you between visits to see how you're doing and watch for any side effects.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States
Georgia